The role of Pdgfra+ fibroblasts in lung fibrosis and alveolar homeostasis
Pdgfra成纤维细胞在肺纤维化和肺泡稳态中的作用
基本信息
- 批准号:8679394
- 负责人:
- 金额:$ 11.14万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-05-05 至 2019-04-30
- 项目状态:已结题
- 来源:
- 关键词:3-DimensionalAddressAdvisory CommitteesAlveolarAreaAwardBehaviorBiological AssayBleomycinCell Culture TechniquesCell SeparationCellsCellular biologyCicatrixCollagenDataDevelopmentDifferentiation and GrowthDiseaseDrug TargetingEducational CurriculumEnvironmentEpithelialEpithelial CellsExtracellular MatrixFibroblastsFibrosisFlow CytometryFluorescence-Activated Cell SortingFutureGasesGene Expression ProfilingGenesGeneticGenomicsGoalsGrowthHamman-Rich syndromeHandHealthHomeostasisHumanHuman GeneticsHyaluronanHyaluronic AcidImmunohistochemistryIn VitroIndividualInjuryKnock-in MouseKnowledgeLaboratoriesLinkLoxP-flanked alleleLungLung ComplianceLung diseasesMediatingMediator of activation proteinMentorsMentorshipMesenchymalMesenchymeModelingMusMutationMyofibroblastOrganoidsPathogenesisPathologicPhysiciansPlatelet-Derived Growth Factor alpha ReceptorPopulationPositioning AttributeProductionProliferatingPulmonary FibrosisResearchResearch Project GrantsRespiratory FailureRespiratory MechanicsRoleScientistSignal PathwaySignal TransductionSmooth Muscle Actin Staining MethodSourceStem cellsStromal CellsStructureSupporting CellSystemTechniquesTestingTimeTrainingTransplantationWorkalveolar epitheliumalveolar homeostasisbasecell typecombatdesigndisease characteristiceffective therapyexperiencehyaluronan synthase 1knowledge baselung injurymouse modelnovelnovel strategiesprecursor cellpublic health relevancerepairedresearch studyresponseself-renewaltherapeutic targettool
项目摘要
PROJECT SUMMARY/ABSTRACT
Career development Goal / Plan: The goal of this project is to provide support and continued mentorship as I
develop into an independent physician-scientist studying pulmonary fibrosis and the role of epithelial-
mesenchymal interaction in the pathogenesis of the disease. The curriculum is specifically designed to
strengthen my theoretical and practical knowledge base in murine models of lung fibrosis, genetic and
phenotypic analysis, and human lung cell biology. This will be achieved through hands on laboratory
experience, didactic training, presentation of data and results, interactions with experts in related fields, and
mentorship from a dedicated advisory committee. As outlined in this proposal, I will have at least 75% of time
protected for research. During this time, I will be able to gain practical expertise in a number of new
techniques, including flow cytometry, fluorescence activated cell sorting (FACS), assessment of murine
respiratory mechanics, and human lung cell isolation and culture. I will also build my knowledge base in
relevant areas of genomics and gene expression analysis. I am well positioned to successfully complete the
work outlined in the proposal given my experienced mentors and the rich and dynamic research environment in
which I will perform the work.
Research Project: Idiopathic pulmonary fibrosis (IPF) is a disease characterized by severe and progressive
alveolar fibrosis that occurs most often in older individuals and that has no effective treatment short of lung
transplant. Based upon human genetic studies revealing a link between mutations in genes specific to type 2
alveolar epithelial cells (AEC2s) and familial forms of pulmonary fibrosis, it is accepted that abnormalities in the
alveolar epithelium are associated with disease development. We lack knowledge, however, of how these
epithelial abnormalities trigger the exuberant response from the underlying mesenchyme that leads to
significant and progressive scar formation. We also are unaware of which cells give rise to the pathologic
myofibroblasts that are characteristic of the disease. I have identified a unique population of fibroblasts in the
lung mesenchyme that are likely to be a source of myofibroblasts. These cells, which express PDGF receptor
alpha (Pdgfra), lie in close proximity to AEC2s and, after bleomycin lung injury, proliferate, up-regulate
myofibroblast markers, and express pro-fibrotic mediators such as hyaluronic acid synthase 2 (Has2). I have
also shown that these cells support the clonal growth and differentiation of murine AEC2s in a 3-dimensional
murine culture system, suggesting that they are critical components of the alveolar epithelial cell niche. I
hypothesize that Pdgfra+ fibroblasts are a source of myofibroblasts following bleomycin lung injury, that these
cells produce pro-fibrotic mediators such as hyaluronan (HA) and Has2 when triggered, and that these cells
are critical components of the human AEC2 niche during homeostasis.
I will test these hypotheses in the following specific aims: AIM 1: To determine if Pdgfra+ fibroblasts give
rise to myofibroblasts after bleomycin lung injury. AIM 2: To test the hypothesis that Pdgfra+ fibroblasts are a
major source of the pro-fibrotic mediators HA and Has2 in the development of bleomycin-induced pulmonary
fibrosis. AIM 3: To test the hypothesis that primary human PDGFRa+ fibroblasts support the survival,
proliferation, and differentiation of human AEC2s, thereby serving as components of the AEC2 niche.
项目总结/摘要
职业发展目标/计划:本项目的目标是提供支持和持续的指导,因为我
发展成为一个独立的医生,科学家研究肺纤维化和上皮细胞的作用,
间充质相互作用在疾病的发病机制。该课程是专门设计,
加强了我在肺纤维化小鼠模型、遗传和
表型分析和人类肺细胞生物学。这将通过实验室实践来实现
经验,教学培训,数据和结果的介绍,与相关领域专家的互动,以及
一个专门的咨询委员会的指导。正如这份提案中所概述的,我将有至少75%的时间
保护研究。在此期间,我将能够获得一些新的实用专业知识,
技术,包括流式细胞术、荧光激活细胞分选术(FACS)、评估小鼠免疫缺陷病毒(HCV)的能力。
呼吸力学和人肺细胞分离和培养。我还将建立我的知识基础,
基因组学和基因表达分析的相关领域。我有能力成功完成
我在建议书中概述的工作,考虑到我经验丰富的导师和丰富而充满活力的研究环境,
我来完成这项工作
研究项目:特发性肺纤维化(IPF)是一种以严重和进行性为特征的疾病,
肺泡纤维化最常发生在老年人中,除了肺部外没有有效的治疗方法。
移植基于人类遗传学研究揭示了2型糖尿病特异性基因突变之间的联系,
肺泡上皮细胞(AEC 2)和家族性肺纤维化,公认的是,
肺泡上皮细胞与疾病发展有关。然而,我们缺乏知识,
上皮细胞异常触发了下层间充质的旺盛反应,
显著和进行性瘢痕形成。我们也不知道是哪些细胞引起了病理性
肌成纤维细胞是疾病的特征。我发现了一个独特的成纤维细胞群,
肺间充质可能是肌成纤维细胞的来源。这些表达PDGF受体的细胞
Pdgfra α与AEC 2非常接近,在博来霉素肺损伤后,
肌成纤维细胞标志物,并表达促纤维化介质,如透明质酸合成酶2(Has 2)。我有
还表明这些细胞支持小鼠AEC 2的克隆生长和分化,
小鼠培养系统,表明它们是肺泡上皮细胞龛的关键组成部分。我
假设Pdgfra+成纤维细胞是博来霉素肺损伤后肌成纤维细胞来源,
细胞产生促纤维化介质,如透明质酸(HA)和Has 2,当触发时,这些细胞
是体内平衡过程中人类AEC 2生态位的关键组成部分。
目的1:确定Pdgfra+成纤维细胞是否能产生细胞因子。
博莱霉素肺损伤后肌成纤维细胞增多。目的2:验证Pdgfra+成纤维细胞是一种细胞因子的假说。
促纤维化介质HA和Has 2在博来霉素诱导的肺纤维化发展中的主要来源
纤维化目的3:为了检验原代人PDGFRa+成纤维细胞支持存活的假设,
增殖和分化,从而充当AEC 2小生境的组分。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Christina Eleanor Barkauskas其他文献
Christina Eleanor Barkauskas的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Christina Eleanor Barkauskas', 18)}}的其他基金
The Intermountain West-Atlantic Center (InterACT) for the APS Phenotyping Consortium
APS 表型联盟的山间西大西洋中心 (InterACT)
- 批准号:
10649343 - 财政年份:2023
- 资助金额:
$ 11.14万 - 项目类别:
The role of Pdgfra+ fibroblasts in lung fibrosis and alveolar homeostasis
Pdgfra成纤维细胞在肺纤维化和肺泡稳态中的作用
- 批准号:
8845610 - 财政年份:2014
- 资助金额:
$ 11.14万 - 项目类别:
The role of Pdgfra+ fibroblasts in lung fibrosis and alveolar homeostasis
Pdgfra成纤维细胞在肺纤维化和肺泡稳态中的作用
- 批准号:
9039142 - 财政年份:2014
- 资助金额:
$ 11.14万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 11.14万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 11.14万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 11.14万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 11.14万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 11.14万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 11.14万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 11.14万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 11.14万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 11.14万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 11.14万 - 项目类别:
Research Grant














{{item.name}}会员




